Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy.
暂无分享,去创建一个
G. Fenalti | L. LeBrun | Dan Zhu | B. Pagarigan | T. Tran | K. Leftheris | D. Cashion | A. Kulkarni | J. Riggs | J. Boylan | K. Condroski | L. Tehrani | Mark A. Nagy | K. E. Fultz | S. Bahmanyar | J. Elsner | D. Robinson | Rama Krishna Narla | Xiaohui Peng